Orphenadrine Citrate Pills Are Subject To A New Recall Best Life
RELATED: If You Have Any of These 7 Medications, Stop Using Them Now, FDA Warns. On March 21, pharmaceutical company Sandoz Inc. announced that it was issuing a nationwide recall of 13 lots of Orphenadrine Citrate 100 mg Extended Release (ER) Tablets, according to a release posted on the U.S. Food & Drug Administration (FDA) site on March 22. The presence of a “nitrosamine impurity” was found during recent testing....